N

Novai

22 employees

Novai is a disruptive British biotech start-up with an AI supported retinal biomarker for use in glaucoma and AMD clinical trials.

Basic info

Industry

biotechnology research

Sectors

Neurodegeneration
Biotechnology
Pharmaceutical
Artificial Intelligence
Opthalmology
Glaucoma
Parkinson's Disease
Biomarker
Multiple Sclerosis
Clinical Trials
Alzheimer's Disease
Drug Development
Retinal
Age-related Macular Degeneration

Date founded

2020

Funding rounds raised

Total raised

$2.3M

from 5 investors over 5 rounds

N

Novai raised $1M on January 24, 2023

Investors: SFC Capital

N

Novai raised $2.3M on October 15, 2021

Investors: SFC Capital and Ascension Ventures

N

Novai raised $1.4M on February 17, 2021

Investors: SFC Capital

N

Novai raised $624K on April 15, 2020

Investors: SFC Capital

FAQ